ACP Journal Club. Rifaximin maintained remission from hepatic encephalopathy longer than placebo in patients with cirrhosis (Q42936083)

From Wikidata
Jump to navigation Jump to search
scientific article published on August 2010
edit
Language Label Description Also known as
English
ACP Journal Club. Rifaximin maintained remission from hepatic encephalopathy longer than placebo in patients with cirrhosis
scientific article published on August 2010

    Statements

    ACP Journal Club. Rifaximin maintained remission from hepatic encephalopathy longer than placebo in patients with cirrhosis (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit